STAGE III PANCREATIC CANCER AJCC V8
Clinical trials for STAGE III PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light-activated therapy may boost immune attack on hard-to-treat pancreatic cancer
Disease control Recruiting nowThis study tests a new combination for people with pancreatic cancer that cannot be surgically removed. It uses a light-activated drug (verteporfin) to make tumors more sensitive to an immunotherapy drug (pembrolizumab), plus standard chemotherapy. The goal is to see if this appr…
Matched conditions: STAGE III PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 01, 2026 15:44 UTC
-
New drug TR-002 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new chemotherapy drug called TR-002 in people with advanced solid tumors (including pancreatic cancer) that have stopped responding to standard treatments. The main goals are to find the safest dose and understand side effects. About 52 adults will …
Matched conditions: STAGE III PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New hope for pancreatic cancer: drug combo targets tumor growth
Disease control Recruiting nowThis early-phase study tests whether adding bosentan to standard chemotherapy can help control pancreatic cancer that cannot be removed by surgery. About 21 adults will receive the combination to find the safest dose and check for side effects. The goal is to slow or stop cancer …
Matched conditions: STAGE III PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New cocktail aims to shrink inoperable pancreatic tumors
Disease control Recruiting nowThis early-phase study tests whether combining a targeted drug (olaparib), an immunotherapy (durvalumab), and radiation is safe for people with locally advanced pancreatic cancer that cannot be surgically removed. About 18 participants will receive the combination after initial c…
Matched conditions: STAGE III PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
Ear seeds may curb cancer appetite loss
Symptom relief Recruiting nowThis study tests whether a simple, non-invasive technique called auricular acupressure (using small pellets on the ear) can improve appetite and prevent weight loss in people with advanced stomach, esophageal, or pancreatic cancer. Researchers will enroll 66 patients to see if th…
Matched conditions: STAGE III PANCREATIC CANCER AJCC V8
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 01, 2026 15:38 UTC